Objectives : This study was undertaken to determine the in vitro antioxidant activity of the extract for Chilgitang herb-acupuncture solution (CHAS).
Methods : The radical scavenging capacity was tested by 2,2-diphenyl- 1-picryl-hydrazyl (DPPH), hypox...
Objectives : This study was undertaken to determine the in vitro antioxidant activity of the extract for Chilgitang herb-acupuncture solution (CHAS).
Methods : The radical scavenging capacity was tested by 2,2-diphenyl- 1-picryl-hydrazyl (DPPH), hypoxanthine-xanthine oxidase system, DCFH-DA assay, nitric oxide and peroxynitrite generating system. In addition, antioxidant activity on copper and AAPH mediated human low?density lipoprotein (LDL) oxidation was measured by using TBARS assay and relative electrophoretic mobility assay. The amount of total phenolic compounds was assayed by by the Folin-Ciocalteu method.
Results : CHAS revealed a potent scavenging activity on DPPH radical (82%), superoxide anions (73%), hydroxyl radical(63%), nitric oxide (99%) and peroxynitrite (99%). Moreover, CHAS showed a strong inhibitory effect (59%) on FeCl2-ascorbic acid induced lipid peroxidation of rat liver homogenate. Moreover, CHAS markedly inhibited copper (81%) and AAPH (56%)?mediated LDL oxidation, and effectively suppressed the electrophoretic mobility during exposure of human LDL to copper ions. CHAS (82 mg/g) contained a higher concentration of total phenolic compounds than that of water extract (45 mg/g) obtained from Chilgitang.
Conclusions : These results indicate that CHAS may protect against ROS- or RNS involved diseases, including cardiovascular diseases.